Literature DB >> 7860069

Factor XKetchikan: a variant molecule in which Gly replaces a Gla residue at position 14 in the light chain.

D J Kim1, A R Thompson, H L James.   

Abstract

To seek the possible molecular defect in a patient with deficient factor X plasma procoagulant activity, factor X gene exosn and splice junctions were subjected to heteroduplex analyses and sequencing. A mutation in exon 2 was confirmed as substitution of A by G at nucleotide position 206, coding for Gly instead of a Glu which is a normal precursor for gamma-carboxylated glutamic acid (Gla) at amino acid position 14. An abolished TaqI restriction site was used to indicate homozygosity of the defect, but occurrence of a gene deletion with attendant heterozygosity could not be excluded. The deletion of a Gla residue could affect the Ca(2+)-binding properties of factor X or confer a flexibility interfering with the interactive properties of the light chain. The defect could explain the decreased functional activity of circulating factor X and the mild bleeding tendency of the propositus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860069     DOI: 10.1007/bf00209404

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Molecular recognition in the activation of human blood coagulation factor X.

Authors:  A Chattopadhyay; D S Fair
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

Review 3.  Vitamin K-dependent carboxylase.

Authors:  J W Suttie
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  The importance of specific gamma-carboxyglutamic acid residues in prothrombin. Evaluation by site-specific mutagenesis.

Authors:  J V Ratcliffe; B Furie; B C Furie
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

5.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

6.  Combined functional and immunochemical analysis of normal and abnormal human factor X.

Authors:  D S Fair; E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

7.  Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343.

Authors:  H L James; A Girolami; D S Fair
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

8.  Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity.

Authors:  L Zhang; A Jhingan; F J Castellino
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

9.  Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg").

Authors:  H H Watzke; K Lechner; H R Roberts; S V Reddy; D J Welsch; P Friedman; G Mahr; P Jagadeeswaran; D M Monroe; K A High
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

10.  Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta.

Authors:  K Fujikawa; K Titani; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.